Johan Luthman
Tracked across 2 events · 13 articles · First seen Apr 13, 2026 · Last active Jun 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Johan Luthman, EVP and Head of Research & Development at Lundbeck, commented on the progress in neuroscience and Lundbeck's approach to drug development.
Apr 13, 2026 · 6 articles
Business
Impact: Johan Luthman, EVP and Head of Research and Development at Lundbeck, expressed satisfaction with the orphan drug designation, highlighting the company's commitment to rare diseases.
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Johan Luthman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard